Celebrating Quality Day at C2C Pharma Ltd.

On 14 November 2024, C2C Pharma Ltd. celebrated Quality Day, reaffirming our unwavering commitment to manufacturing high-quality, affordable medicines for patients worldwide.

The day began with an inauguration ceremony graced by Director & CEO Anis Uz Zaman and Director Shykh Zaman. In his speech, Mr. Anis Uz Zaman emphasized the company’s core principle, “Quality is our Top Priority”, and shared the vision of making high-quality medicines accessible globally. Mr. Shykh Zaman highlighted the importance of ensuring quality as a continuous process, emphasizing that as a new company, we have the unique opportunity to stand out by delivering high-quality medicines with timely delivery for patient care.

The event featured a rally on Quality Day, symbolizing our shared dedication to excellence. Following this, the Head of Quality Operations led all employees in a Quality Oath, assuring our commitment to adhere to the highest quality standards, aligned with the values and behaviors of C2C Pharma.

The celebration included engaging and insightful sessions, such as a Quality Quiz, workshop on Good Documentation Practices, and a thought-provoking session titled “What is Quality or Not Quality”. Team-building games designed around quality principles added an element of fun while emphasizing the importance of collaboration.

A poster exhibition focusing on the theme “Quality is Everyone’s Responsibility” showcased creative expressions of our commitment to quality. This year’s theme reflected our belief that quality is not confined to Quality Operations department but is a shared responsibility of every individual at C2C Pharma.

We are proud of our team’s dedication and enthusiasm, which made Quality Day a resounding success. This celebration strengthens our resolve to continually improve and provide medicines that meet the highest standards, ensuring the health and well-being of patients everywhere.

Here’s to building a future where quality leads the way!

Prev post
Next post

Leave A Reply